No Data
No Data
No Data
No Data
No Data
GSK's Application for Jemperli's Expanded Indication Accepted by FDA for Priority Review
GSK (GSK) said Wednesday that the US Food and Drug Administration granted priority review to its supplemental Biologics License Application for Jemperli in combination with chemotherapy to expand trea
MT NewswiresApr 24 10:38 ET
GSK Reports Positive Data for Gonorrhea Treatment Gepotidacin, Shingles Vaccine Shingrix
GSK (GSK) on Wednesday reported positive results from phase 3 trials for gepotidacin, an oral antibiotic to treat urogenital gonorrhea, and Shingrix, its shingles vaccine. The drug maker said gepotida
MT NewswiresApr 17 09:18 ET
GSK's Uncomplicated Urogenital Gonorrhea Treatment Meets Primary Endpoint in Late-stage Trial
British drugmaker GSK (GSK.L) on Wednesday said a phase 3 trial of its gepotidacin drug for treating uncomplicated urogenital gonorrhea in adolescents and adults met its primary endpoint. The oral ant
MT NewswiresApr 17 03:13 ET
GSK Says US FDA Accepts Meningococcal Vaccine Candidate for Regulatory Review
GSK (GSK) said in a regulatory filing Tuesday that the US Food and Drug Administration has accepted for review the company's biologics license application for its meningococcal ABCWY vaccine candidate
MT NewswiresApr 16 08:14 ET
GSK PLC Sponsored ADR (GSK) Is Attracting Investor Attention: Here Is What You Should Know
Yahoo FinanceMar 28 09:00 ET
Has GSK PLC Sponsored ADR (GSK) Outpaced Other Medical Stocks This Year?
Yahoo FinanceMar 13 09:40 ET
No Data
No Data